Cost-Effectiveness Of Midostaurin In The Treatment Of Acute Myeloid Leukemia With The FLT3 Mutation In Spain.
Arenaza A, Diez R, Esteve J, Di Nicolantonio R, Gostkorzewicz J, Martínez C, Martínez Llinàs D, Martinez-Lopez J, Montesinos P, Moure-Fernández A, Sierra J, Vinent JL.
Arenaza A, et al. Among authors: gostkorzewicz j.
Clinicoecon Outcomes Res. 2019 Nov 13;11:683-694. doi: 10.2147/CEOR.S222879. eCollection 2019.
Clinicoecon Outcomes Res. 2019.
PMID: 32009807
Free PMC article.